About Us
Founded in 2015, Biofrontera Inc. is a U.S.-headquartered biopharmaceutical company with a passion for treating dermatological conditions utilizing photodynamic therapy (PDT).
As a comprehensive pharmaceutical company, Biofrontera Inc. includes control of clinical innovation to commercialization with full ownership of all product patents, NDA and IND related to the US market. Biofrontera Inc. leads commercial strategy and execution, pursuing US market expansion and medical education.
Founded in 2022, Biofrontera Discovery GmbH, a wholly owned German subsidiary, serves as the scientific and operational backbone of Biofrontera Inc, with a focus on clinical development, regulatory excellence, quality assurance, and manufacturing.
Our Commitment
We are committed to fostering enduring relationships with our stakeholders, built on a foundation of trust, collaboration, and the willingness to be responsive to their evolving needs. Through our unwavering dedication we will continue to lead the way in transforming PDT and improving lives.
Our vision
We believe in the value of Photodynamic Therapy and will realize its full potential by working in partnership with our stakeholders, enabling access to all patients, and becoming the market leader in this field.
Our mission
Our mission to advance Photodynamic Therapy to new heights of excellence through innovation in product developments that redefine standards of efficacy, accessibility, and patient satisfaction.
